FIBROBIOLOGICS, INC.

Press Releases FibroBiologics, Inc.

Equities

FBLG

US31573L1052

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-14 pm EDT			5-day change	1st Jan Change
11.3 ^USD	+10.35%		+22.56%	0.00%

Apr. 25	FibroBiologics, Inc. Plans to Collaborate with Charles River Laboratories to Manufacture Fibroblast-Based Spheroids	CI
Apr. 04	Fibrobiologics Presents Data from Dermal Fibroblast Spheroid-Based Treatment of Chronic Wounds in A Diabetes Mouse Model At Advanced Wound Care Summit USA	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

FibroBiologics Files 2024 First Quarter Report	May. 14	GL
FibroBiologics to Present at the BIO International Convention 2024	May. 07	GL
FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based Spheroids	Apr. 25	GL
FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent Office	Apr. 11	GL
FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USA	Apr. 04	GL
FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of Lupus	Mar. 28	GL
FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment	Mar. 19	PR
FibroBiologics to Present at Advanced Wound Care Summit USA	Mar. 13	PR
FibroBiologics Appoints Ruben A. Garcia as General Counsel	Mar. 06	PR
FibroBiologics Files 2023 Form 10-K Annual Report	Feb. 29	PR
FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis Forum	Feb. 21	AQ
FibroBiologics to Present Preclinical and Clinical Data at the 2024 Americas Committee for Treatment and Research in Multiple Sclerosis (ACTRIMS) Forum	Feb. 20	PR
FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases	Feb. 13	PR
FibroBiologics Announces Three United States Patents for Fibroblast Technology	Feb. 08	PR
FibroBiologics Announces Three Japanese Patents on Fibroblast Technology	Feb. 06	PR

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

SIGN UP NOW